Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artekin versus Coartem in children with uncomplicated Plasmodium falciparum malaria
ISRCTN16263443Phase 3Completed
- Sponsor
- Leadiant Biosciences
- Start
- May 2005
- Modality
- Small Molecules
01
Overview
Phase 3 trial of dihydroartemisinin + piperaquine and lumefantrine, sponsored by Leadiant Biosciences. Started May 2005; status: completed.
02
Drugs
dihydroartemisinin + piperaquinelumefantrine
Beyond the preview
Go deeper on ISRCTN16263443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16263443.